z-logo
open-access-imgOpen Access
Levels in stroke patients of CSF astroprotein, an astrocyte-specific cerebroprotein.
Author(s) -
Tōru Hayakawa,
Y Ushio,
Takahiro Mori,
Norio Arita,
Toshiki Yoshimine,
Yasutaka Maeda,
Katsuji Shimizu,
A Myoga
Publication year - 1979
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/01.str.10.6.685
Subject(s) - medicine , subarachnoid hemorrhage , intracerebral hemorrhage , cerebrospinal fluid , astrocyte , glial fibrillary acidic protein , stroke (engine) , cerebral infarction , infarction , pathology , ischemia , central nervous system , immunohistochemistry , myocardial infarction , mechanical engineering , engineering
Astroprotein (an astrocyte-specific cerebroprotein) levels in cerebrospinal fluid (CSF) were determined by radioimmunoassay in 47 stroke patients. (Astroprotein is immunologically identical to glial fibrillary acidic protein.) Astroprotein levels in CSF increased markedly in acute cases of intracerebral hemorrhage and slightly to moderately in some acute cases of subarachnoid hemorrhage and cerebral infarction. In intracerebral hemorrhage, CSF astroprotein levels in the acute stage of the ictus reflected the size of the lesion and were used to estimate the clinical outcome. In subarachnoid hemorrhage and cerebral infarction, CSF astroprotein levels were related to the general neurological state. Evidence obtained indicated that fundamentally different destructive and/or degenerative processes in the brain may be involved in intracerebral hemorrhage, subarachnoid hemorrhage and cerebral infarction and that determination of CSF astroprotein may have clinical significance in stroke patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom